Wonderbelly,which markets itself as a healthy-for-you antacid alternative to Tums, is planning a Series A as it plots more retail rollouts, CEO Noah Krafttells Axios.
Why it matters: Over-the-counter products have drawn interest from consumer product goods companies, early-stage investors, biotech firms and large retailers.